Wall Street Is Sleeping on These 3 Ultra-High-Yield Dividend Stocks
Three famous dividend names trade well below their five-year highs while their CEOs publicly draw lines in the sand around the payout. Whether the cash flow actually backs that confidence is a different question entirely.
Wall Street has spent the last several years discounting a handful of famous dividend names on fears of patent cliffs, volume declines, and commodity swings. But the checks keep clearing. Pfizer (NYSE:PFE | PFE Price Prediction) still trades 20.8% below where it was five years ago, even as management just reaffirmed its payout in front of a looming loss-of-exclusivity window. Two other names, one industrial and one energy major, are in the same conversation. Here is where the yields sit, and whether the coverage supports them.
Pfizer: A 6% Yield With Management Drawing a Line in the Sand
Pfizer currently yields 6.15% on an annualized forward dividend of $1.72 per share, paid as a $0.43 quarterly distribution. The dividend was $0.42 in 2024 and has stepped up every year in the recent record, from $0.36 in 2019 to today.
Pfizer reaffirmed adjusted diluted EPS guidance of $2.80 to $3.00 for 2026, comfortably above the $1.72 annual payout. Second-quarter operating cash flow was $3.45 billion, and the company returned $4.9 billion to shareholders via the dividend in the first half. CEO Albert Bourla said flatly, “We feel extremely confident that, even in the most stretched scenarios we are running, we will be able to maintain our dividend.” Leverage ended the quarter at 2.7 times, and management now expects $6.7 billion in net cost savings through 2029.
In terms of the bull case, Pfizer’s launched and acquired products grew 18% operationally, and the pharma giant sees a path to high single-digit revenue growth after the LOE period ends in 2028. However, the implied risk is the same LOE cliff. Pfizer’s own guidance absorbs a meaningful headwind, and any acceleration of generic entry would pressure the coverage cushion.
UPS: Yield Above 6% After a Multiyear Reset
UPS (NYSE:UPS) yields 6.39% on an annualized forward dividend of $6.56 per share, or $1.64 quarterly. That payout has held steady across the seven most recent quarters, after a large step-up from $1.02 in 2021 to $1.52 in 2022. The stock is still 30.79% below its price five years ago.
Management guided full-year adjusted EPS of approximately $7.22, against a planned dividend payout of around $5.4 billion. Expected 2026 free cash flow is approximately $5.5 billion, essentially matching the dividend. Cash on the balance sheet stood at $4.7 billion with no commercial paper outstanding. CEO Carol Tomé framed the turnaround directly: “Incremental volume today carries materially better economics than before because of the structural changes we’ve made.”
The bull case is the completed Amazon glide-down, roughly $3 billion of savings landing in 2026, and U.S. domestic operating margin already back to 9.2%. The risk remains that free cash flow barely covers the dividend, and U.S. average daily volume still fell 3.3% year-over-year. Any macro air pocket makes that math a little uncomfortable.
Chevron: Lower Yield, but the Coverage Is a Fortress
Chevron (NYSE:CVX) rounds out the group as a high-yield income name rather than an ultra-high-yield one. The stock yields 3.44% on a $1.78 quarterly payout, with an annualized forward dividend of $7.12 per share. The per-share amount has stepped up every year in the record shown, from $1.29 in 2020 to $1.78 in 2026. Skepticism here is less about the payout and more about long-term oil demand.
Recent Q2 adjusted earnings came in at $6.06 per share, adjusted free cash flow was $15.4 billion, and Chevron cut debt by more than $8 billion in the quarter. Net debt to cash flow from operations sits at 0.6 times. Management hit $3 billion of structural cost reductions six months ahead of schedule and reaffirmed a long-term target of adjusted free cash flow growth averaging greater than 10% per year through 2030.
The record U.S. upstream production of nearly 2.1 million barrels of oil equivalent per day makes a solid bull case for the stock, along with Hess assets producing free cash flow roughly double the incremental dividends, and forward P/E holding at 13. However, earnings are still tethered to Brent, and CEO Mike Wirth’s $6 billion affiliate distribution guidance is set at $70 Brent.
What Ties These Three Payouts Together
These three names share a pattern the market keeps missing: durable cash flow, explicit CEO commitments to the payout, and multiyear cost programs that widen the coverage cushion each quarter. A 6%+ yield usually means the market suspects a cut is coming, and sometimes it is right (we walked through the seven warning signs that separate a real trap from a discounted payer in a free report here). Pfizer and UPS clear those tests while their businesses reset. Chevron pays less but backs it with the strongest balance sheet of the three. For income investors, the group offers a rare combination of skepticism-driven pricing and management teams putting the dividend first.
Contact [email protected] for any questions or corrections.
Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.
